These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4594189)

  • 1. A double-blind controlled study of MK-486 in Parkinson's disease.
    Schwartz AM; Olanow CW; Spencer A
    Trans Am Neurol Assoc; 1973; 98():301-3. PubMed ID: 4594189
    [No Abstract]   [Full Text] [Related]  

  • 2. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 3. MK 486 and levodopa in treatment of Parkinsonism.
    Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
    Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of fusaric acid in Parkinson's disease.
    Herskovits E; Figueroa Gacitua E
    Medicina (B Aires); 1973; 33(1):51-8. PubMed ID: 4573120
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
    Olanow CW; Alberts MJ
    Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB
    Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R; Koller WC
    Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy.
    Mones RJ
    N Y State J Med; 1974 Jan; 74(1):47-51. PubMed ID: 4591989
    [No Abstract]   [Full Text] [Related]  

  • 10. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U
    Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbidopa in Parkinson disease and in nausea and vomiting of levodopa.
    Markham C; Diamond SG; Treciokas LJ
    Arch Neurol; 1974 Aug; 31(2):128-33. PubMed ID: 4834974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of the treatment of Parkinson's diseases with carbidopa and L-Dopa].
    Cáceres AF
    Rev Fac Cienc Med Cordoba; 1974; 32(2):161-74. PubMed ID: 4619691
    [No Abstract]   [Full Text] [Related]  

  • 14. Parallel double-blind study of pergolide in Parkinson's disease.
    Jankovic J; Orman J
    Adv Neurol; 1987; 45():551-4. PubMed ID: 3548265
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
    [No Abstract]   [Full Text] [Related]  

  • 16. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM; Brody JA; Chase TN
    Neurology; 1974 Mar; 24(3):263-5. PubMed ID: 4855953
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract]   [Full Text] [Related]  

  • 20. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.